Immunosuppressive Extracellular Vesicles as a Linking Factor in the Development of Tumor and Endometriotic Lesions in the Gynecologic Tract

Cells. 2022 Apr 28;11(9):1483. doi: 10.3390/cells11091483.

Abstract

Both gynecological tumors and endometriosis require for their development a favorable environment, termed in the case of tumors a "pre-metastatic niche" and in case of endometriosis a "pro-endometriotic niche". This is characterized by chronic inflammation and immunosuppression that support the further progression of initial lesions. This microenvironment is established and shaped in the course of a vivid cross-talk between the tumor or endometrial cells with other stromal, endothelial and immune cells. There is emerging evidence that extracellular vesicles (EVs) play a key role in this cellular communication, mediating both in tumors and endometriosis similar immunosuppressive and pro-inflammatory mechanisms. In this review, we discuss the latest findings about EVs as immunosuppressive factors, highlighting the parallels between gynecological tumors and endometriosis. Furthermore, we outline their role as potential diagnostic or prognostic biomarkers as well as their future in therapeutic applications.

Keywords: chronic inflammatory microenvironment; endometrial cancer; endometriosis; extracellular vesicles; immune dysfunction; immunosuppression; ovarian cancer; pro-endometriotic niche; tumor microenvironment.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Communication
  • Endometriosis* / pathology
  • Endometrium / pathology
  • Extracellular Vesicles* / pathology
  • Female
  • Genital Neoplasms, Female* / pathology
  • Humans
  • Immunosuppressive Agents
  • Tumor Microenvironment

Substances

  • Immunosuppressive Agents

Grants and funding

This research was funded by National Science Centre under grant 2021/41/B/NZ6/02291; and NAWA under grant PPI/APM/2019/1/00051/U001.